CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
The effect of RaceRunning on cardiometabolic disease risk factors and functional mobility in young people with moderate-to-severe cerebral palsy: protocol for a feasibility study
Authors
G Andreopoulou
N Anokye
+9 more
H Dines
K Jagadamma
F Kennedy
P Koufaki
S Phillips
J Ryan
N Theis
M van der Linden
P van Schie
Publication date
1 July 2020
Publisher
'BMJ'
Doi
Abstract
Copyright © Author(s) (or their employer(s)) 2020. Introduction: There is consistent evidence that people with cerebral (CP) do not engage in the recommended physical activity guidelines for the general population from a young age. Participation in moderate-to-vigorous physical activity is particularly reduced in people with CP who have moderate-to-severe disability. RaceRunning is a growing disability sport that provides an opportunity for people with moderate-to-severe disability to participate in physical activity in the community. It allows those who are unable to walk independently, to propel themselves using a RaceRunning bike, which has a breastplate for support but no pedals. The aim of this study is to examine the feasibility and acceptability of RaceRunning for young people with moderate-to-severe CP and the feasibility of conducting a definitive study of the effect of RaceRunning on cardiometabolic disease risk factors and functional mobility. Methods and analysis: Twenty-five young people (age 5-21 yr) with CP or acquired brain injury affecting co-ordination will be included in this single arm intervention study. Participants will take part in one RaceRunning session each week for 24 weeks. Outcomes assessed at baseline, 12 and 24 weeks include body mass index, waist circumference, blood pressure, muscle strength, cardiorespiratory fitness, physical activity and sedentary behaviour, functional mobility, activity competence and psychosocial impact. Adverse events will be systematically recorded throughout the 24 weeks. Focus groups will be conducted with participants and/or parents to explore their views and experiences of taking part in RaceRunning. Ethics and dissemination: Approval has been granted by Queen Margaret University Research Ethics Committee (REC) and the South East of Scotland REC. Results will be disseminated through peer-reviewed journals and distributed to people with CP and their families through RaceRunning and Athletic Clubs, NHS trusts, and organisations for people with disabilities. Trial registration number: ClinicalTrials.gov Identifier: NCT04034342. Protocol version 1.0; pre-results.Action Medical Research and Chartered Society of Physiotherapy Charitable Trust.Joint award from Action Medical Research and Chartered Society of Physiotherapy Charitable Trust
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
University of Gloucestershire Research Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.glos.ac.uk:8458
Last time updated on 13/06/2020
Queen Margaret University eResearch
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eresearch.qmu.ac.uk:20.500...
Last time updated on 07/07/2020
Sustaining member
Brunel University Research Archive
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:bura.brunel.ac.uk:2438/205...
Last time updated on 18/12/2020
Edinburgh Research Explorer
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:pure.ed.ac.uk:publications...
Last time updated on 31/07/2020